1 Video
2nd Conference
15 Videos
Drug Discovery in Academia and Industry: Bridging the Translational Gap - The Second BCDD Conference, Sep. 14th, 2017
All Rights Reserved
The Story of Sigma-1R Identification as Potential Drug Target for The Treatment of eIF2B-Leukodystrophy
Prof. Orna Elroy-Stein, Department of Cell Research and Immunology, Faculty of Life Sciences, TAU
The Second BCDD Conference Drug Discovery in Academia and Industry: Bridging the Translational Gap Blavatnik Center for Drug Discovery Tel Aviv University 14.9.17
More videos
BLAVATNIK CENTER for Drug Discovery second Annual Conference
Closing Remarks
Climbing the Mountain of Drug Discovery from the Groves of Academe
The Taste of Poisons and of Therapeutic Drugs: Who Cares and How to Predict it
Setting the Bar for Early Phase Innovative Projects in the Pharmaceutical Industry
Highly Efficient Computational Discovery of Novel Pesticides
Designing Micellar Nanocarriers with High Molecular Precision
Small-Molecule Mediated Inhibition of Microbial Cellular Processes
The Story of Sigma-1R Identification as Potential Drug Target for The Treatment of eIF2B-Leukodystrophy
Novel GSK-3 Inhibitors for Treating CNS Disorders
A Patient’s View on Parkinson's and How to Harness The Wisdom of the People for Identifying Novel Drugs
Prof. Abraham Nudelman
Yaakov Litzman
Drug Discovery is a Chemical Enterprise
Welcome
